Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter December 29, 2013

The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer

  • Umar Wazir EMAIL logo , Mai Ahmed , Joanna Bridger , Amanda Harvey , Wen Jiang , Anup Sharma and Kefah Mokbel

Abstract

Lamin A/C (LMNA), lamin B1 (LMNB1) and lamin B receptor (LBR) have key roles in nuclear structural integrity and chromosomal stability. In this study, we have studied the relationships between the mRNA expressions of A-type lamins, LMNB1 and LBR and the clinicopathological parameters in human breast cancer. Samples of breast cancer tissues (n = 115) and associated non-cancerous tissue (ANCT; n = 30) were assessed using reverse transcription and quantitative PCR. Transcript levels were correlated with clinicopathological data. Higher levels of A-type lamins and LMNB1 mRNA expression were seen in ANCT. Higher lamin A/C expression was associated with the early clinical stage (TNM1 vs. TNM3 — 13 vs. 0.21; p = 0.0515), with better clinical outcomes (disease-free survival vs. mortality — 11 vs. 1; p = 0.0326), and with better overall (p = 0.004) and disease-free survival (p = 0.062). The expression of LMNB1 declined with worsening clinical outcome (disease-free vs. mortalities — 0.0011 vs. 0.000; p = 0.0177). LBR mRNA expression was directly associated with tumor grade (grade 1 vs. grade 3 — 0.00 vs. 0.00; p = 0.0479) and Nottingham Prognostic Index (NPI1 vs. NPI3 — 0.00 vs. 0.00; p = 0.0551). To the best of our knowledge, this is the first study to suggest such a role for A-type lamins, lamin B1 and LBR in human breast cancer, identifying an important area for further research.

[1] Bridger, J.M., Foeger, N., Kill, I.R. and Herrmann, H. The nuclear lamina. Both a structural framework and a platform for genome organization. FEBS J.274 (2007) 1354–1361. http://dx.doi.org/10.1111/j.1742-4658.2007.05694.x10.1111/j.1742-4658.2007.05694.xSearch in Google Scholar PubMed

[2] Guelen, L., Pagie, L., Brasset, E., Meuleman, W., Faza, M.B., Talhout, W., Eussen, B.H., de Klein, A., Wessels, L., de Laat, W. and van Steensel, B. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 453 (2008) 948–951. DOI: 10.1038/nature06947. http://dx.doi.org/10.1038/nature0694710.1038/nature06947Search in Google Scholar PubMed

[3] Malhas, A., Lee, C.F., Sanders, R., Saunders, N.J. and Vaux, D.J. Defects in lamin B1 expression or processing affect interphase chromosome position and gene expression. J. Cell Biol. 176 (2007) 593–603. DOI: 10.1083/jcb.200607054. http://dx.doi.org/10.1083/jcb.20060705410.1083/jcb.200607054Search in Google Scholar PubMed PubMed Central

[4] Bridger, J.M., Kill, I.R., O’Farrell, M. and Hutchison, C.J. Internal lamin structures within G1 nuclei of human dermal fibroblasts. J. Cell Sci. 104 (1993) 297–306. Search in Google Scholar

[5] Goldman, A.E., Moir, R.D., Montag-Lowy, M., Stewart, M. and Goldman, R.D. Pathway of incorporation of microinjected lamin A into the nuclear envelope. J. Cell Biol. 119 (1992) 725–735. http://dx.doi.org/10.1083/jcb.119.4.72510.1083/jcb.119.4.725Search in Google Scholar PubMed PubMed Central

[6] Solovei, I., Wang, A.S., Thanisch, K., Schmidt, C.S., Krebs, S., Zwerger, M., Cohen, T.V., Devys, D., Foisner, R., Peichl, L., Herrmann, H., Blum, H., Engelkamp, D., Stewart, C.L., Leonhardt, H. and Joffe, B. LBR and lamin A/C sequentially tether peripheral heterochromatin and inversely regulate differentiation. Cell 152 (2013) 584–598. DOI: 10.1016/j.cell.2013.01.009. http://dx.doi.org/10.1016/j.cell.2013.01.00910.1016/j.cell.2013.01.009Search in Google Scholar PubMed

[7] Zhang, H., Kieckhaefer, J.E. and Cao, K. Mouse models of laminopathies. Aging Cell 12 (2013) 2–10. DOI: 10.1111/acel.12021. http://dx.doi.org/10.1111/acel.1202110.1111/acel.12021Search in Google Scholar PubMed

[8] Worman, H.J., Ostlund, C. and Wang, Y. Diseases of the nuclear envelope. Cold Spring Harb. Perspect. Biol. 2 (2010) a000760. DOI: 10.1101/cshperspect.a000760. http://dx.doi.org/10.1101/cshperspect.a00076010.1101/cshperspect.a000760Search in Google Scholar PubMed PubMed Central

[9] Chi, Y.H., Chen, Z.J. and Jeang, K.T. The nuclear envelopathies and human diseases. J. Biomed. Sci. 16 (2009) 96. DOI: 10.1186/1423-0127-16-96. http://dx.doi.org/10.1186/1423-0127-16-9610.1186/1423-0127-16-96Search in Google Scholar PubMed PubMed Central

[10] Kong, L., Schafer, G., Bu, H., Zhang, Y. and Klocker, H. Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway. Carcinogenesis 33 (2012) 751–759. DOI: 10.1093/carcin/bgs022. http://dx.doi.org/10.1093/carcin/bgs02210.1093/carcin/bgs022Search in Google Scholar PubMed

[11] Helfand, B.T., Wang, Y., Pfleghaar, K., Shimi, T., Taimen, P. and Shumaker, D.K. Chromosomal regions associated with prostate cancer risk localize to lamin B-deficient microdomains and exhibit reduced gene transcription. J. Pathol. 226 (2012) 735–745. DOI: 10.1002/path.3033. http://dx.doi.org/10.1002/path.303310.1002/path.3033Search in Google Scholar PubMed

[12] Luk, J.M. and Liu, A.M. Proteomics of hepatocellular carcinoma in Chinese patients. OMICS 15 (2011) 261–266. DOI: 10.1089/omi.2010.0099. http://dx.doi.org/10.1089/omi.2010.009910.1089/omi.2010.0099Search in Google Scholar PubMed

[13] Al Sarakbi, W., Sasi, W., Jiang, W.G., Roberts, T., Newbold, R.F. and Mokbel, K. The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters. BMC Cancer 9 (2009) 290. DOI: 10.1186/1471-2407-9-290. http://dx.doi.org/10.1186/1471-2407-9-29010.1186/1471-2407-9-290Search in Google Scholar PubMed PubMed Central

[14] Elkak, A., Mokbel, R., Wilson, C., Jiang, W.G., Newbold, R.F. and Mokbel, K. hTERT mRNA expression is associated with a poor clinical outcome in human breast cancer. Anticancer Res. 26 (2006) 4901–4904. Search in Google Scholar

[15] Wazir, U., Jiang, W.G., Sharma, A.K. and Mokbel, K. The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parameters. Anticancer Res. 32 (2012) 671–674. Search in Google Scholar

[16] Jiang, W.G., Watkins, G., Lane, J., Cunnick, G.H., Douglas-Jones, A., Mokbel, K. and Mansel, R.E. Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin. Cancer Res. 9 (2003) 6432–6440. Search in Google Scholar

[17] Lin, F. and Worman, H.J. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J. Biol. Chem. 268 (1993) 16321–16326. Search in Google Scholar

[18] Bonne, G., Di Barletta, M.R., Varnous, S., Becane, H.M., Hammouda, E.H., Merlini, L., Muntoni, F., Greenberg, C.R., Gary, F., Urtizberea, J.A., Duboc, D., Fardeau, M., Toniolo, D. and Schwartz, K. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 21 (1999) 285–288. DOI: 10.1038/6799. http://dx.doi.org/10.1038/679910.1038/6799Search in Google Scholar PubMed

[19] Maraldi, N.M., Capanni, C., Cenni, V., Fini, M. and Lattanzi, G. Laminopathies and lamin-associated signaling pathways. J. Cell Biochem.112 (2011) 979–992. DOI: 10.1002/jcb.22992. http://dx.doi.org/10.1002/jcb.2299210.1002/jcb.22992Search in Google Scholar PubMed

[20] Cenni, V., Capanni, C., Columbaro, M., Ortolani, M., D’Apice, M.R., Novelli, G., Fini, M., Marmiroli, S., Scarano, E., Maraldi, N.M., Squarzoni, S., Prencipe, S. and Lattanzi, G. Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria. Eur. J. Histochem. 55 (2011) e36. DOI: 10.4081/ejh.2011.e36. http://dx.doi.org/10.4081/ejh.2011.e3610.4081/ejh.2011.e36Search in Google Scholar PubMed PubMed Central

[21] Cao, K., Graziotto, J.J., Blair, C.D., Mazzulli, J.R., Erdos, M.R., Krainc, D. and Collins, F.S. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci. Transl. Med. 3 (2011) 89ra58. DOI: 10.1126/scitranslmed.3002346. 10.1126/scitranslmed.3002346Search in Google Scholar PubMed

[22] Ramos, F.J., Chen, S.C., Garelick, M.G., Dai, D.F., Liao, C.Y., Schreiber, K.H., MacKay, V.L., An, E.H., Strong, R., Ladiges, W.C., Rabinovitch, P.S., Kaeberlein, M. and Kennedy, B.K. Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Sci. Transl. Med. 4 (2012) 144ra103. DOI: 10.1126/scitranslmed.3003802. http://dx.doi.org/10.1126/scitranslmed.300380210.1126/scitranslmed.3003802Search in Google Scholar PubMed PubMed Central

[23] Wydner, K.L., McNeil, J.A., Lin, F., Worman, H.J. and Lawrence, J.B. Chromosomal assignment of human nuclear envelope protein genes LMNA, LMNB1, and LBR by fluorescence in situ hybridization. Genomics 32 (1996) 474–478. DOI: 10.1006/geno.1996.0146. http://dx.doi.org/10.1006/geno.1996.014610.1006/geno.1996.0146Search in Google Scholar PubMed

[24] Tsai, M.Y., Wang, S., Heidinger, J.M., Shumaker, D.K., Adam, S.A., Goldman, R.D. and Zheng, Y. A mitotic lamin B matrix induced by RanGTP required for spindle assembly. Science 311 (2006) 1887–1893. DOI: 10.1126/science.1122771. http://dx.doi.org/10.1126/science.112277110.1126/science.1122771Search in Google Scholar PubMed

[25] Worman, H.J. and Bonne, G. “laminopathies”: a wide spectrum of human diseases. Exp. Cell Res. 313 (2007) 2121–2133. DOI: 10.1016/j.yexcr.2007.03.028. http://dx.doi.org/10.1016/j.yexcr.2007.03.02810.1016/j.yexcr.2007.03.028Search in Google Scholar PubMed PubMed Central

[26] Young, S.G., Jung, H.J., Coffinier, C. and Fong, L.G. Understanding the roles of nuclear A- and B-type lamins in brain development. J. Biol. Chem.287 (2012) 16103–16110. DOI: 10.1074/jbc.R112.354407. http://dx.doi.org/10.1074/jbc.R112.35440710.1074/jbc.R112.354407Search in Google Scholar PubMed PubMed Central

[27] Coffeen, C.M., McKenna, C.E., Koeppen, A.H., Plaster, N.M., Maragakis, N., Mihalopoulos, J., Schwankhaus, J.D., Flanigan, K.M., Gregg, R.G., Ptacek, L.J. and Fu, Y.H. Genetic localization of an autosomal dominant leukodystrophy mimicking chronic progressive multiple sclerosis to chromosome 5q31. Hum. Mol. Genet. 9 (2000) 787–793. http://dx.doi.org/10.1093/hmg/9.5.78710.1093/hmg/9.5.787Search in Google Scholar PubMed

[28] Hegele, R.A., Cao, H., Liu, D.M., Costain, G.A., Charlton-Menys, V., Rodger, N.W. and Durrington, P.N. Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am. J. Hum. Genet. 79 (2006) 383–389. DOI: 10.1086/505885. http://dx.doi.org/10.1086/50588510.1086/505885Search in Google Scholar PubMed PubMed Central

[29] Olins, A.L., Rhodes, G., Welch, D.B., Zwerger, M. and Olins, D.E. Lamin B receptor: multi-tasking at the nuclear envelope. Nucleus 1 (2010) 53–70. DOI: 10.4161/nucl.1.1.10515. 10.4161/nucl.1.1.10515Search in Google Scholar PubMed PubMed Central

[30] Hoffmann, K., Sperling, K., Olins, A.L. and Olins, D.E. The granulocyte nucleus and lamin B receptor: avoiding the ovoid. Chromosoma 116 (2007) 227–235. DOI: 10.1007/s00412-007-0094-8. http://dx.doi.org/10.1007/s00412-007-0094-810.1007/s00412-007-0094-8Search in Google Scholar PubMed

[31] Waterham, H.R., Koster, J., Mooyer, P., Noort Gv, G., Kelley, R.I. and Wilcox, W.R. Autosomal recessive hem/greenberg skeletal dysplasia is caused by 3betahydroxysterol delta 14-reductase deficiency due to mutations in the lamin b receptor gene. Am. J. Hum. Genet. 72 (2003) 1013–1017. http://dx.doi.org/10.1086/37393810.1086/373938Search in Google Scholar PubMed PubMed Central

[32] Butin-Israeli, V., Adam, S.A., Goldman, A.E. and Goldman, R.D. Nuclear lamin functions and disease. Trends Genet. 28 (2012) 464–471. DOI: 10.1016/j.tig.2012.06.001. http://dx.doi.org/10.1016/j.tig.2012.06.00110.1016/j.tig.2012.06.001Search in Google Scholar PubMed PubMed Central

[33] Fischer, A.H., Taysavang, P., Weber, C.J. and Wilson, K.L. Nuclear envelope organization in papillary thyroid carcinoma. Histol. Histopathol.16 (2001) 1–14. Search in Google Scholar

[34] Foster, C.R., Robson, J.L., Simon, W.J., Twigg, J., Cruikshank, D., Wilson, R.G. and Hutchison, C.J. The role of lamin A in cytoskeleton organization in colorectal cancer cells: a proteomic investigation. Nucleus 2 (2011) 434–443. DOI: 10.4161/nucl.2.5.17775. http://dx.doi.org/10.4161/nucl.2.5.1777510.4161/nucl.2.5.17775Search in Google Scholar PubMed PubMed Central

[35] Willis, N.D., Cox, T.R., Rahman-Casans, S.F., Smits, K., Przyborski, S.A., van den Brandt, P., van Engeland, M., Weijenberg, M., Wilson, R.G., de Bruine, A. and Hutchison, C.J. Lamin A/C is a risk biomarker in colorectal cancer. PLoS ONE 3 (2008) e2988. DOI: 10.1371/journal.pone.0002988. http://dx.doi.org/10.1371/journal.pone.000298810.1371/journal.pone.0002988Search in Google Scholar PubMed PubMed Central

[36] Hudson, M.E., Pozdnyakova, I., Haines, K., Mor, G. and Snyder, M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl. Acad. Sci. U S A 104 (2007) 17494–17499. DOI: 10.1073/pnas.0708572104. http://dx.doi.org/10.1073/pnas.070857210410.1073/pnas.0708572104Search in Google Scholar PubMed PubMed Central

[37] Kaufmann, S.H., Mabry, M., Jasti, R. and Shaper, J.H. Differential expression of nuclear envelope lamins A and C in human lung cancer cell lines. Cancer Res. 51 (1991) 581–586. Search in Google Scholar

[38] Broers, J.L., Raymond, Y., Rot, M.K., Kuijpers, H., Wagenaar, S.S. and Ramaekers, F.C. Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am. J. Pathol. 143 (1993) 211–220. Search in Google Scholar

[39] Moss, S.F., Krivosheyev, V., de Souza, A., Chin, K., Gaetz, H.P., Chaudhary, N., Worman, H.J. and Holt, P.R. Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms. Gut 45 (1999) 723–729. http://dx.doi.org/10.1136/gut.45.5.72310.1136/gut.45.5.723Search in Google Scholar PubMed PubMed Central

[40] Venables, R.S., McLean, S., Luny, D., Moteleb, E., Morley, S., Quinlan, R.A., Lane, E.B. and Hutchison, C.J. Expression of individual lamins in basal cell carcinomas of the skin. Br. J. Cancer 84 (2001) 512–519. DOI: 10.1054/bjoc.2000.1632. http://dx.doi.org/10.1054/bjoc.2000.163210.1054/bjoc.2000.1632Search in Google Scholar PubMed PubMed Central

[41] Capo-chichi, C.D., Cai, K.Q., Simpkins, F., Ganjei-Azar, P., Godwin, A.K. and Xu, X.X. Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer. BMC Med. 9 (2011) 28. DOI: 10.1186/1741-7015-9-28. http://dx.doi.org/10.1186/1741-7015-9-2810.1186/1741-7015-9-28Search in Google Scholar PubMed PubMed Central

[42] Wu, Z., Wu, L., Weng, D., Xu, D., Geng, J. and Zhao, F. Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma. J. Exp. Clin. Cancer Res. 28 (2009) 8. DOI: 10.1186/1756-9966-28-8. http://dx.doi.org/10.1186/1756-9966-28-810.1186/1756-9966-28-8Search in Google Scholar PubMed PubMed Central

[43] Agrelo, R., Setien, F., Espada, J., Artiga, M.J., Rodriguez, M., Perez-Rosado, A., Sanchez-Aguilera, A., Fraga, M.F., Piris, M.A. and Esteller, M. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. J. Clin. Oncol. 23 (2005) 3940–3947. DOI: 10.1200/JCO.2005.11.650. http://dx.doi.org/10.1200/JCO.2005.11.65010.1200/JCO.2005.11.650Search in Google Scholar PubMed

[44] Wong, K.F. and Luk, J.M. Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinoma. Methods Mol. Biol. 909 (2012) 295–310. DOI: 10.1007/978-1-61779-959-4_19. 10.1007/978-1-61779-959-4_19Search in Google Scholar PubMed

[45] Sun, S., Xu, M.Z., Poon, R.T., Day, P.J. and Luk, J.M. Circulating lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients. J. Proteome Res. 9 (2010) 70–78. DOI: 10.1021/pr9002118. http://dx.doi.org/10.1021/pr900211810.1021/pr9002118Search in Google Scholar PubMed

[46] Coradeghini, R., Barboro, P., Rubagotti, A., Boccardo, F., Parodi, S., Carmignani, G., D’Arrigo, C., Patrone, E. and Balbi, C. Differential expression of nuclear lamins in normal and cancerous prostate tissues. Oncol. Rep. 15 (2006) 609–613. Search in Google Scholar

[47] Wazir, U., Newbold, R.F., Jiang, W.G., Sharma, A.K. and Mokbel, K. Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer. Oncol. Rep. 29 (2013) 1969–1974. DOI: 10.3892/or.2013.2346. 10.3892/or.2013.2346Search in Google Scholar PubMed

[48] Wander, S.A., Zhao, D., Besser, A.H., Hong, F., Wei, J., Ince, T.A., Milikowski, C., Bishopric, N.H., Minn, A.J., Creighton, C.J. and Slingerland, J.M. PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy. Breast Cancer Res. Treat. (2013) 369–381. DOI: 10.1007/s10549-012-2389-6. 10.1007/s10549-012-2389-6Search in Google Scholar PubMed PubMed Central

Published Online: 2013-12-29
Published in Print: 2013-12-1

© 2013 University of Wrocław, Poland

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 19.3.2024 from https://www.degruyter.com/document/doi/10.2478/s11658-013-0109-9/html
Scroll to top button